Natural history of surgically treated high-risk prostate cancer

Abstract Background No data exist on the patterns of biochemical recurrence (BCR) and their effect on survival in patients with high-risk prostate cancer (PCa) treated with surgery. The aim of our investigation was to evaluate the natural history of PCa in patients treated with radical prostatectomy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2015-04, Vol.33 (4), p.163.e7-163.e13
Hauptverfasser: Briganti, Alberto, M.D, Karnes, Robert Jeffrey, M.D, Gandaglia, Giorgio, M.D, Spahn, Martin, M.D, Gontero, Paolo, M.D, Tosco, Lorenzo, M.D, Kneitz, Burkhard, M.D, Chun, Felix K.H., M.D, Zaffuto, Emanuele, M.D, Sun, Maxine, M.D, Graefen, Markus, M.D, Marchioro, Giansilvio, M.D, Frohneberg, Detlef, M.D, Giona, Simone, M.D, Karakiewicz, Pierre I., M.D, Van Poppel, Hein, M.D, Montorsi, Francesco, M.D, Joniau, Steven, M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background No data exist on the patterns of biochemical recurrence (BCR) and their effect on survival in patients with high-risk prostate cancer (PCa) treated with surgery. The aim of our investigation was to evaluate the natural history of PCa in patients treated with radical prostatectomy (RP) alone. Materials and methods Overall, 2,065 patients with high-risk PCa treated with RP at 7 tertiary referral centers between 1991 and 2011 were identified. First, we calculated the probability of experiencing BCR after surgery. Particularly, we relied on conditional survival estimates for BCR after RP. Competing-risks regression analyses were then used to evaluate the effect of time to BCR on the risk of cancer-specific mortality (CSM). Results Median follow-up was 70 months. Overall, the 5-year BCR-free survival rate was 55.2%. Given the BCR-free survivorship at 1, 2, 3, 4, and 5 years, the BCR-free survival rates improved by+7.6%,+4.1%,+4.8%,+3.2%, and+3.7%, respectively. Overall, the 10-year CSM rate was 14.8%. When patients were stratified according to time to BCR, patients experiencing BCR within 36 months from surgery had higher 10-year CSM rates compared with those experiencing late BCR (19.1% vs. 4.4%; P
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2014.11.018